(Q33184500)

23 July 2017

title

Minimal impact of CMV infection on long-term survival after liver transplantation (English)

1 reference

23 July 2017

main subject

liver transplantation

1 reference

7

Neuhaus P

1 reference

23 July 2017

Seehofer D

1

1 reference

23 July 2017

Rayes N

2

1 reference

23 July 2017

Steinmüller T

3

1 reference

23 July 2017

Schmidt CA

4

1 reference

23 July 2017

Settmacher U

5

1 reference

23 July 2017

Müller AR

6

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Transplantation Proceedings

23 July 2017

published in

1 reference

23 July 2017

volume

34

1 reference

23 July 2017

issue

6

1 reference

23 July 2017

page(s)

2272-2273

1 reference

Cytomegalovirus infection and disease after liver transplantation

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

Cytomegalovirus Disease as a Risk Factor for Graft Loss and Death After Orthotopic Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

A Multivariate Analysis of Risk Factors for Cytomegalovirus Infection in Liver-Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903231-1

7 January 2021

10.1016/S0041-1345(02)03231-1

Identifiers

DOI

1 reference

23 July 2017

1 reference